XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity and Earnings Per Common Share
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Shareholders' Equity and Earnings Per Common Share Shareholders’ Equity and Earnings Per Common Share
On December 17, 2024, our Board of Directors authorized a share repurchase plan (the “Repurchase Plan”) to buy back up to 1,100,000 shares of our outstanding common stock through December 31, 2025. Shares would be repurchased through open market transactions, though we could execute repurchases through other means, such as privately negotiated transactions. The timing and amount of any share repurchases will depend on a variety of factors, including, among others, securities law restrictions, the trading price of our common stock, regulatory requirements, potential alternative uses for capital, and our financial performance. During the three and nine month periods ended September 30, 2025 we repurchased 13,732 and 266,008 shares of common stock, respectively for an aggregate purchase price of $0.41 million and $7.77 million, respectively. During the nine month period ended September 30, 2024 there were no shares of common stock repurchased.
A reconciliation of basic and diluted net income per common share follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In thousands, except
per share data)
Net income$17,502 $13,810 $49,969 $48,329 
Weighted average shares outstanding (1)20,702 20,896 20,797 20,892 
Stock units for deferred compensation plan for non-employee directors173 182 175 178 
Performance share units28 34 27 27 
Effect of stock options2 3 2 3 
Weighted average shares outstanding for calculation of diluted earnings per share20,905 21,115 21,001 21,100 
Net income per common share
Basic (1)$0.85 $0.66 $2.40 $2.31 
Diluted$0.84 $0.65 $2.38 $2.29 
(1)Basic net income per common share includes weighted average common shares outstanding during the period and participating share awards.
Weighted average stock options outstanding that were not considered in computing diluted net income per common share because they were anti-dilutive were zero for the three and nine month periods ended September 30, 2025 and 2024, respectively.